Venus Remedies Ltd
Know More397.05↑-0.10 (-0.03%)
10:59 AM,8th Dec 2023396.75↑-3.25 (-0.81%)
11:04 AM,8th Dec 2023BSE : 526953
NSE : VENUSREM
Sector : Health care
ISIN Code : INE411B01019
- NSE
- BSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: Dec 08 2023 | 11:04 AM IST
| Market Cap (₹ Cr) | 530 |
Turnover (₹ Cr) | 0.29 |
Volume (Shares) | 72839 |
Face Value | 10 |
52-WK High | 418.00 |
52-WK High Date | 07 Dec 2023 |
52-WK Low | 145.80 |
52-WK Low Date | 22 Feb 2023 |
All Time High | 639.00 |
All Time High Date | 09 Aug 2021 |
All Time Low | 18.80 |
All Time Low Date | 19 Jul 2019 |
Venus Remedies Ltd
Incorporated in 1989 as Venus Glucose Pvt Ltd the company was converted into public limited company in 1994 and then changed into Venus Remedies Limited. The company was promoted and managed by Chaudhary & Family. The company was mainly engaged in I/V fluids & injectablesceftazidimeamlodipinegliclazidelisinopril.The production was started in 1991 with Intravenous/Intramuscular injectible forms at Panchkula district at Haryana. In 1994 it introduced Eye/Ear/Nose drops. The company received the certificate as 'WHO-GMP' as specified by WHOGeneva. Venus Remedies set up a Cephalosporin project with an Australian collaboration with US-FDA standards at a cost of Rs.4.5 crores. The company is manufacturing injections for the top companies like Panacea Biotech ltdMorepan Labortories ltd etc.In 2001 with the help of Product Development Committee(PDC) Venus Remedies had introduced 13 new products in the Animal Health Division namely Megox-3000Paroxin-3000Pisa-3000MicalRonidDexolyte and Detox.
Announcement
View MoreVenus Remedies Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 530 |
| EPS - TTM (₹) [S] | 14.92 |
| P/E Ratio (X) [S] | 1.09 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 30.00 |
| Latest Dividend Date | 23 Sep 2013 |
| Dividend Yield (%) | - |
| Book Value Share (₹) [S] | 364.78 |
| P/B Ratio (₹) [S] | 1.09 |
| [*C] Consolidated [*S] Standalone | |
Funds Owing this Stock
| Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
|---|---|---|---|
| Motilal Oswal S&P BSE Healthcare ETF | 0.00 | 79 | 0.02 |
Research Reports
| Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
|---|---|---|---|---|
| Data Not Found |
Stock Strength
| Today's Low/High | 388.00 409.00 |
| Week Low/High | 368.70 418.00 |
| Month Low/High | 275.20 418.00 |
| Year Low/High | 145.80 418.00 |
| All time Low/High | 1.00 639.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 2.80% | 2.72% | 3.32 | 3.50% |
| 1 Month | 37.60% | 37.89% | 7.31 | 7.89% |
| 3 Month | 70.12% | 70.66% | 4.69 | 5.84% |
| 6 Month | 76.70% | 76.62% | 10.94 | 12.57% |
| 1 Year | 106.05% | 106.26% | 11.43 | 12.73% |
| 3 Year | 197.30% | 198.20% | 52.88 | 56.63% |
Company Info
Company Information
Chairman & Managing Director : Pawan Chaudhary
Joint Managing Director : Manu Chaudhary
Deputy Managing Director : Peeyush Jain
Executive Director : Ashutosh Jain
Independent Director : Gilbert Wenzel
Independent Director : S. K. Chadha
Company Sec. & Compli. Officer : Neha Kodan
Independent Director : Navdeep Sud
Independent Director : Savita Gupta
Whole-time Director : Akshansh Chaudhary
Independent Director : Nps Monga
Registered Office: S C No 857 Cabin No 10 2nd Flr, N A C Manimajra,Chandigarh,Chandigarh-160101 Ph:
